{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:10:40Z","timestamp":1772640640416,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T00:00:00Z","timestamp":1527120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s11011-018-0224-4","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T21:15:56Z","timestamp":1527196556000},"page":"1393-1399","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Elevated plasma homocysteine levels are associated with disability progression in patients with multiple sclerosis"],"prefix":"10.1007","volume":"33","author":[{"given":"Sayonara Rangel","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamires","family":"Flauzino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz Sardinha","family":"Sabino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Paula","family":"Kallaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela Frizon","family":"Alfieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damacio Ramon","family":"Kaimen-Maciel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena Kaminami","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine Regina Delicato","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcell Alysson Batisti","family":"Lozovoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edna Maria Vissoci","family":"Reiche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaias","family":"Dichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9a Name Colado","family":"Sim\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,24]]},"reference":[{"key":"224_CR1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3988\/jcn.2014.10.4.281","volume":"10","author":"R Ansari","year":"2014","unstructured":"Ansari R, Mahta A, Mallack E et al (2014) Hyperhomocysteinemia and neurological disorders: a review. J Clin Neurol 10:281\u2013288","journal-title":"J Clin Neurol"},{"key":"224_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/1028415031000115945","volume":"6","author":"HT Besler","year":"2003","unstructured":"Besler HT, Comoglu S (2003) Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis. Nutr Neurosci 6:189\u2013196","journal-title":"Nutr Neurosci"},{"key":"224_CR3","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.msard.2017.08.004","volume":"17","author":"E Dardiotis","year":"2017","unstructured":"Dardiotis E, Arseniou S, Sokratous M et al (2017) Vitamin B12, folate and homocysteine levels and multiple sclerosis: a meta-analysis. Mult Scler Relat Disord 17:190\u2013197","journal-title":"Mult Scler Relat Disord"},{"key":"224_CR4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00702-005-0409-y","volume":"113","author":"B Engelhardt","year":"2006","unstructured":"Engelhardt B (2006) Molecular mechanisms involved in T cell migration across the blood-brain barrier. J Neural Transm 113:477\u2013485","journal-title":"J Neural Transm"},{"key":"224_CR5","first-page":"1","volume":"21","author":"EM Fahmy","year":"2018","unstructured":"Fahmy EM, Elfayoumy NM, Abdelalim AM et al (2018) Relation of serum levels of homocysteine, vitamin B12 and folate to cognitive functions in multiple sclerosis patients. Int J Neurosci 21:1\u20137","journal-title":"Int J Neurosci"},{"key":"224_CR6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1161\/01.STR.0000115161.10646.67","volume":"35","author":"FM Faraci","year":"2004","unstructured":"Faraci FM, Lentz SR (2004) Hiperhomocysteinemia, oxidative stress and cerebral vascular dysfunction. Stroke 35:345\u2013347","journal-title":"Stroke"},{"key":"224_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1365-2990.2010.01140.x","volume":"37","author":"J Greenwood","year":"2011","unstructured":"Greenwood J, Heasman SJ, Alvarez JI (2011) Review: leucocyte-endothelial cell crosstalk at the blood-brain barrier: a prerequisite for successful immune cell entry to the brain. Neuropathol Appl Neurobiol 37:24\u201339","journal-title":"Neuropathol Appl Neurobiol"},{"key":"224_CR8","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jcma.2015.08.010","volume":"79","author":"I Guzel","year":"2016","unstructured":"Guzel I, Mungan S, Oztekin ZN et al (2016) Is there an association between the expanded disability status scale and inflammatory markers in multiple sclerosis? J Chin Med Assoc 79:54\u201357","journal-title":"J Chin Med Assoc"},{"key":"224_CR9","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/ana.410380210","volume":"38","author":"HP Hartung","year":"1995","unstructured":"Hartung HP, Reiners K, Archelos JJ et al (1995) Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: correlation with magnetic resonance imaging. Ann Neurol 38:186\u2013193","journal-title":"Ann Neurol"},{"key":"224_CR10","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/jnr.10416","volume":"70","author":"PI Ho","year":"2002","unstructured":"Ho PI, Ortiz D, Rogers E et al (2002) Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage. J Neurosci Res 70:694\u2013702","journal-title":"J Neurosci Res"},{"key":"224_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jneuroim.2016.10.003","volume":"300","author":"A Kalinowska-Lyszczars","year":"2016","unstructured":"Kalinowska-Lyszczars A, Michalak S, Pawlak MA et al (2016) Serum sPECAM-1 and Svcam-1 levels are associated with conversion to multiple sclerosis in patients with optic neuritis. J Neuroimmunol 300:11\u201314","journal-title":"J Neuroimmunol"},{"key":"224_CR12","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1182\/blood-2005-06-2506","volume":"107","author":"AF Kamath","year":"2006","unstructured":"Kamath AF, Chauhan AK, Kisucka J et al (2006) Elevated levels of homocysteine compromise blood-brain barrier integrity in mice. Blood 107:591\u2013593","journal-title":"Blood"},{"key":"224_CR13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jocn.2008.05.015","volume":"16","author":"B Kocer","year":"2009","unstructured":"Kocer B, Engur S, Ak F et al (2009) Serum vitamin B12, folate, and homocysteine levels and their association with clinical and electrophysiological parameters in multiple sclerosis. J Clin Neurosci 16:399\u2013403","journal-title":"J Clin Neurosci"},{"key":"224_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jns.2015.02.009","volume":"350","author":"MW Koch","year":"2015","unstructured":"Koch MW, George S, Wall W et al (2015) Serum NSE level and disability progression in multiple sclerosis. J Neurol Sci 350:46\u201350","journal-title":"J Neurol Sci"},{"key":"224_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jneuroim.2005.06.019","volume":"167","author":"B Kuenz","year":"2005","unstructured":"Kuenz B, Lutterotti A, Khalil M et al (2005) Plasma levels of soluble adhesion molecules S-pecam, SP-selectin and E-selectin are associated with relapsing-remmiting disease course of multiple sclerosis. J Neuroimmunol 167:143\u2013149","journal-title":"J Neuroimmunol"},{"key":"224_CR16","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444\u20131452","journal-title":"Neurology"},{"key":"224_CR17","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1016\/j.clineuro.2013.05.007","volume":"115","author":"M Moghaddasi","year":"2013","unstructured":"Moghaddasi M, Mamarabadi M, Mohebi N et al (2013) Homocysteine, vitamin B12 and folate levels in Iranian patients with multiple sclerosis: a case control study. Clin Neurol Neurosur 115:1802\u20131805","journal-title":"Clin Neurol Neurosur"},{"key":"224_CR18","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1016\/j.febslet.2006.04.088","volume":"580","author":"R Obeid","year":"2006","unstructured":"Obeid R, Herrmann W (2006) Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett 580:2994\u20133005","journal-title":"FEBS Lett"},{"key":"224_CR19","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/S0271-5317(03)00133-7","volume":"23","author":"MF Panunzio","year":"2003","unstructured":"Panunzio MF, Pisano A, Antoniciello A et al (2003) Supplementation with fruit and vegetable concentrate decreases plasma homocysteine levels in a dietary controlled trial. Nutr Res 23:1221\u20131228","journal-title":"Nutr Res"},{"key":"224_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the \u201cMcDonald criteria\u201d. Ann Neurol 69:293\u2013302","journal-title":"Ann Neurol"},{"key":"224_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.neuroscience.2015.06.038","volume":"302","author":"L Probert","year":"2015","unstructured":"Probert L (2015) TNF and its receptors in the CNS: the essential, the desirable and the deleterious effects. Neuroscience 302:2\u201322","journal-title":"Neuroscience"},{"key":"224_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1136\/jnnp.2005.072199","volume":"77","author":"GSM Ramsaransing","year":"2006","unstructured":"Ramsaransing GSM, Fokkema MR, Teelken A et al (2006) Plasma homocysteine levels in multiple sclerosis. J Neurol Neurosurg Psychiatry 77:189\u2013192","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"224_CR23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ncl.2011.01.006","volume":"29","author":"C Renoux","year":"2011","unstructured":"Renoux C (2011) Natural history of multiple sclerosis: long-term prognostic factors. Neurol Clin 29:293\u2013308","journal-title":"Neurol Clin"},{"key":"224_CR24","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/135245859800400317","volume":"4","author":"P Rieckmann","year":"1998","unstructured":"Rieckmann P, Altenhofen B, Riegel A et al (1998) Correlation of soluble adhesion molecules in blood and cerebrospinal fluid with magnetic resonance imaging activity in patients with multiple sclerosis. Mult Scler 4:178\u2013182","journal-title":"Mult Scler"},{"key":"224_CR25","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1212\/01.WNL.0000156155.19270.F8","volume":"64","author":"RHSR Roxburgh","year":"2005","unstructured":"Roxburgh RHSR, Seaman SR, Masterman T et al (2005) Multiple sclerosis severity score: using disability and disease duration to rate disease severity. Neurology 64:1144\u20131154","journal-title":"Neurology"},{"key":"224_CR26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s00415-007-0668-7","volume":"255","author":"C Russo","year":"2008","unstructured":"Russo C, Morabito F, Luise F et al (2008) Hyperhomocysteinemia is associated with cognitive impairment in multiple sclerosis. J Neurol 255:64\u201369","journal-title":"J Neurol"},{"key":"224_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1476-511X-9-19","volume":"9","author":"G Salemi","year":"2010","unstructured":"Salemi G, Gueli MC, Vitale F et al (2010) Blood lipids, homocysteine, stress factors and vitamins in clinically stable multiple sclerosis patients. Lipids Health Dis 9:19","journal-title":"Lipids Health Dis"},{"key":"224_CR28","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3233\/JAD-2006-9404","volume":"9","author":"S Seshadri","year":"2006","unstructured":"Seshadri S (2006) Elevated plasma homocysteine levels: risk factors or risk marker for the development of dementia and Alzheimer \u2018s disease? J Alzheimers Dis 9:393\u2013398","journal-title":"J Alzheimers Dis"},{"key":"224_CR29","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1056\/NEJM199108153250704","volume":"325","author":"MK Sharief","year":"1991","unstructured":"Sharief MK, Hentges R (1991) Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N Engl J Med 325:467\u2013472","journal-title":"N Engl J Med"},{"key":"224_CR30","doi-asserted-by":"crossref","first-page":"747","DOI":"10.33549\/physiolres.932897","volume":"64","author":"H Skovierov\u00e1","year":"2015","unstructured":"Skovierov\u00e1 H, Mahmood S, Blahovcov\u00e1 E et al (2015) Effect of homocysteine on survival of human glial cells. Physiol Res 64:747\u2013754","journal-title":"Physiol Res"},{"key":"224_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17101733","volume":"17","author":"H Skovierov\u00e1","year":"2016","unstructured":"Skovierov\u00e1 H, Vidomanov\u00e1 E, Mahmood S et al (2016) The molecular and cellular effect of homocysteine metabolism imbalance on human health. Int Mol Sci 17:E1733","journal-title":"Int Mol Sci"},{"key":"224_CR32","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1136\/jnnp.2008.151555","volume":"79","author":"CE Teunissen","year":"2008","unstructured":"Teunissen CE, Kilestein J, Kragt JJ et al (2008) Serum homocysteine levels in relation to clinical progression in multiple sclerosis. J Neurol Neurosurg Psychiatry 79:1349\u20131353","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"224_CR33","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00415-012-6622-3","volume":"260","author":"P Wipfler","year":"2013","unstructured":"Wipfler P, Heikkinen A, Harrer A et al (2013) Circadian rhythmicity of inflammatory serum parameters: a neglected issue in the search of biomarkers in multiple sclerosis. J Neurol 260:221\u2013227","journal-title":"J Neurol"},{"key":"224_CR34","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jocn.2010.12.022","volume":"18","author":"Y Zhu","year":"2011","unstructured":"Zhu Y, He ZY, Liu HN (2011) Meta-analysis of the relationship between homocysteine, vitamin B12, folate and multiple sclerosis. J Clin Neurosci 18:933\u2013938","journal-title":"J Clin Neurosci"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-018-0224-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-018-0224-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-018-0224-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T12:01:01Z","timestamp":1604318461000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-018-0224-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,24]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["224"],"URL":"https:\/\/doi.org\/10.1007\/s11011-018-0224-4","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,24]]},"assertion":[{"value":"6 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}